AstraZeneca -> Clinical Pharmacometrican opportunity

(Senior) Clinical Pharmacometrician CVMD Quantitative Clinical Pharmacology - Early Clinical Development Salary: Competitive Location: Gothenburg, Sweden Do you have expertise and experience in mathematical modelling and simulation and its application in drug development, plus a pharmaceutical industry R&D background? Do you have a good understanding of the concepts of pharmacokinetics and drug disposition? If you're a talented and engaged individual, this is an opportunity to join AstraZeneca as a (Senior) Clinical Pharmacometrician in Gothenburg supporting projects within the therapy area of Cardiovascular and Metabolic Disorders AstraZeneca is a world-leading pharmaceutical company, we focus on discovering and developing medicines that make a real difference to millions of patients. We are building a state-of-the-art quantitative clinical pharmacology group with a diverse and uniquely skilled team of pharmacometricians in Gothenburg, where two of our key therapeutic areas are located. You'll thrive in an environment that inspires innovation, encourages multidisciplinary team-working and collaboration with academia, and rewards original scientific thinking. Main duties and responsibilities Working closely with clinical pharmacology scientists, physicians and other scientists, you'll apply modelling to support the design and interpretation of clinical studies and influence key decisions in early and late clinical development. The work includes integration of relevant data, such as dose information, pharmacokinetics, biomarkers and clinical endpoints within and across studies, compounds and development stages. Support to informative trial designs using simulations and efficient modeling statistics is an important focus area for us. An area to grow is quantitative systems pharmacology and mechanistic modelling approaches for more informative translation of disease and drug knowledge. In collaboration with clinical pharmacology scientists, you'll represent Quantitative Clinical Pharmacology and be responsible for identifying and executing modelling to support model based drug development. You will communicate your findings to other scientists within and outside of AstraZeneca and publish them in peer reviewed journals. Essential requirements You must have: · PhD degree preferred or equivalent relevant experience in quantitative science · Strong quantitative modelling skills, e.g. expert knowledge in mathematics, statistics, mechanistic systems pharmacology modelling, quantitative translational scaling, model-based meta-analyses · Background and a comprehensive understanding of clinical pharmacology aspects of drug development · Experience in pharmaceutical R&D · Working knowledge of pharmacokinetics and its clinical application · Biological understanding of disease and drug action · Excellent oral and written communication skills. You'll need real passion for your subject, along with a high level of integrity, plus the ability to work in a multi-disciplinary setting that comprises a number of specialists in their fields, including physicians, scientists and statisticians. Desirable requirements You will ideally have: · Recognised scientific expertise demonstrated by scientific publishing in the field of clinical pharmacology · Early or late phase clinical development experience/awareness. More information For more information about the position please contact: Bengt Hamrén at +46 31 7762201 Welcome with your application no later than April 30, 2017. https://job-search.astrazeneca.com/job/gothenburg/senior-clinical-pharmacometrician-cvmd-quantitative-clinical-pharmacology-early-clinical-development/7684/4313026 Bengt Hamrén, PhD Quantitative Clinical Pharmacology Lead CVMD _____________________________________________________________________________________________ AstraZeneca R&D Mölndal Research and Development | Quantitative Clinical Pharmacology SE 431 83 Mölndal, Sweden T: +46 (0)31 776 22 01 Mobile: + 46 (0) 768-774811 e-mail: [email protected]<mailto:[email protected]> Please consider the environment before printing this e-mail ________________________________ Confidentiality Notice: This message is private and may contain confidential and proprietary information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this message is not permitted and may be unlawful.